Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cross Protection | 1 | 2021 | 373 | 0.72 | Why? |
| Bacterial Capsules | 1 | 2017 | 39 | 0.70 | Why? |
| Chaperonin 60 | 1 | 2017 | 42 | 0.69 | Why? |
| Hepatitis B | 1 | 2021 | 888 | 0.48 | Why? |
| Streptococcus pneumoniae | 1 | 2017 | 827 | 0.46 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.38 | Why? |
| Biological Evolution | 2 | 2017 | 641 | 0.23 | Why? |
| Patient-Specific Modeling | 1 | 2021 | 60 | 0.21 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.21 | Why? |
| Dengue Virus | 2 | 2018 | 910 | 0.21 | Why? |
| Immunity, Heterologous | 1 | 2021 | 129 | 0.21 | Why? |
| Phylogeography | 2 | 2021 | 824 | 0.20 | Why? |
| Operon | 1 | 2017 | 12 | 0.18 | Why? |
| Adenoviruses, Simian | 1 | 2017 | 52 | 0.18 | Why? |
| Epistasis, Genetic | 1 | 2017 | 35 | 0.17 | Why? |
| Serotyping | 1 | 2017 | 154 | 0.17 | Why? |
| Phylogeny | 6 | 2021 | 13341 | 0.17 | Why? |
| Health Services Accessibility | 1 | 2021 | 10697 | 0.16 | Why? |
| Probability | 1 | 2020 | 923 | 0.16 | Why? |
| Endemic Diseases | 1 | 2021 | 480 | 0.16 | Why? |
| Dengue Vaccines | 1 | 2018 | 123 | 0.16 | Why? |
| Blood Donors | 2 | 2020 | 2956 | 0.15 | Why? |
| Dengue | 2 | 2018 | 1565 | 0.14 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.13 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.13 | Why? |
| Chikungunya Fever | 1 | 2017 | 345 | 0.13 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.12 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.12 | Why? |
| Ecosystem | 1 | 2017 | 776 | 0.12 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.12 | Why? |
| Genome, Viral | 4 | 2021 | 13157 | 0.12 | Why? |
| Drug Carriers | 1 | 2017 | 590 | 0.11 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.09 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.09 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.09 | Why? |
| South Africa | 3 | 2021 | 3326 | 0.08 | Why? |
| Hepatitis C | 1 | 2017 | 1514 | 0.08 | Why? |
| Brazil | 5 | 2021 | 12582 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| Geography | 2 | 2021 | 1801 | 0.07 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.07 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.06 | Why? |
| Healthcare Disparities | 1 | 2021 | 3893 | 0.06 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.06 | Why? |
| Genotype | 3 | 2017 | 4697 | 0.06 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.06 | Why? |
| Machine Learning | 1 | 2017 | 4395 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Whole Genome Sequencing | 2 | 2021 | 3239 | 0.05 | Why? |
| Molecular Typing | 1 | 2021 | 280 | 0.05 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.05 | Why? |
| Disease Outbreaks | 2 | 2017 | 27595 | 0.05 | Why? |
| Genetic Fitness | 1 | 2021 | 339 | 0.05 | Why? |
| Sympatry | 1 | 2017 | 2 | 0.05 | Why? |
| Introduced Species | 1 | 2017 | 13 | 0.05 | Why? |
| DNA Mutational Analysis | 1 | 2021 | 581 | 0.05 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.04 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2021 | 253789 | 0.04 | Why? |
| Geography, Medical | 1 | 2020 | 537 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2020 | 907 | 0.04 | Why? |
| Humans | 14 | 2021 | 930598 | 0.04 | Why? |
| Selection, Genetic | 1 | 2021 | 691 | 0.04 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2017 | 325 | 0.04 | Why? |
| Scotland | 1 | 2020 | 1119 | 0.04 | Why? |
| Viral Vaccines | 1 | 2017 | 7560 | 0.04 | Why? |
| Conserved Sequence | 1 | 2017 | 751 | 0.04 | Why? |
| Serogroup | 1 | 2017 | 510 | 0.04 | Why? |
| Models, Immunological | 1 | 2020 | 727 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Datasets as Topic | 1 | 2021 | 1404 | 0.03 | Why? |
| Population Dynamics | 1 | 2017 | 378 | 0.03 | Why? |
| Thailand | 1 | 2018 | 1155 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Seroepidemiologic Studies | 2 | 2020 | 10017 | 0.03 | Why? |
| Colombia | 1 | 2018 | 1241 | 0.03 | Why? |
| RNA, Viral | 2 | 2017 | 32276 | 0.03 | Why? |
| Vietnam | 1 | 2018 | 1665 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.03 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.03 | Why? |
| Amino Acid Sequence | 1 | 2021 | 6049 | 0.02 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.02 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Exanthema | 1 | 2017 | 1097 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Immunization Programs | 1 | 2018 | 2006 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2017 | 3231 | 0.02 | Why? |
| Travel | 1 | 2021 | 7220 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.01 | Why? |
| Male | 4 | 2020 | 367725 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Female | 4 | 2020 | 380317 | 0.01 | Why? |
| Animals | 2 | 2017 | 78931 | 0.01 | Why? |
| Adult | 3 | 2020 | 244371 | 0.01 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.01 | Why? |
| Aged | 2 | 2020 | 215776 | 0.01 | Why? |
| Middle Aged | 2 | 2020 | 270681 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.01 | Why? |